Stocks · Health care · Pharmaceutical Preparations

Oruka Therapeutics, Inc.

ORKA Clue Score22

United States Fiscal year ends December CIK 0000907654 Results filed 10 Aug 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (120 mo)

$5.71M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$348.24M

$2.72M on a plan · $336.57M straight out of an exercise

Sold at will

$8.95M

34 of 151 sales

Net

−$342.53M

−$3.24M against sales at will